<?xml version="1.0" encoding="UTF-8"?>
<p id="p0115">An inhaled corticosteroid compound, ciclesonide has been suggested as a potential drug against the COVID-19 (
 <xref rid="bib38" ref-type="bibr">Matsuyama et al., 2020</xref>). The compound suppressed SARS-CoV-2 replication in cultured cells, where the suppression was mainly related to the targeting viral nonstructural protein 15 (nsp 15) (
 <xref rid="bib38" ref-type="bibr">Matsuyama et al., 2020</xref>). It is expected that inhaled ciclesonide can reduce viral replication and host inflammation in the lungs.
</p>
